MATTHEW J. BRUNNER, M.D.; ROCCO V. LOBRAICO JR., M.D.
This content is PDF only. Please click on the PDF icon to access.
Dermatomyositis is a fairly well-defined clinical entity, usually readily distinguishable from lupus erythematosus disseminata, scleredema, early scleroderma, pellagra and trichinosis, the conditions it most closely resembles. Little is known of the possible causative factors, the general belief being that the disease perhaps has some toxic or infectious basis. Streptococci have been particularly suspect because of the frequently obtained history of sore throat, scarlatina or other acute respiratory infection preceding the appearance of dermatomyositis.1, 2, 3, 4, 5, 6 Some investigators have been able to isolate streptococci, staphylococci and other organisms7 from the affected muscles, and Ormsby and Montgomery8 state that
BRUNNER MJ, LOBRAICO RV. DERMATOMYOSITIS AS AN INDEX OF MALIGNANT NEOPLASM: REPORT OF A CASE AND REVIEW OF THE LITERATURE1. Ann Intern Med. 1951;34:1269–1273. doi: 10.7326/0003-4819-34-5-1269
Download citation file:
© 2019
Published: Ann Intern Med. 1951;34(5):1269-1273.
DOI: 10.7326/0003-4819-34-5-1269
Hematology/Oncology, Rheumatology.
Results provided by: